| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. | Chief Executive Officer | Common Stock | 36.5K | $561K | $15.36 | Sep 9, 2025 | Direct |
| Protagenic Therapeutics, Inc.\new | Director | PTIX Common stock Options | 75K | $131K | $1.74 | Mar 25, 2024 | Direct |
| AGENUS INC | Director | Common Stock | 19.7K | $61.4K | $3.11 | May 2, 2025 | Direct |
| AGENUS INC | Director | Stock Option | 300K | Nov 14, 2024 | Direct | ||
| MiNK Therapeutics, Inc. | Chief Executive Officer | Stock Option (Right to Buy) | 50K | Sep 9, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | Sep 9, 2025 | 1 | -$82.2K | 4/A | Oct 3, 2025 | Chief Executive Officer |
| AGEN | AGENUS INC | May 2, 2025 | 1 | $1.81K | 4 | May 6, 2025 | Director |
| AGEN | AGENUS INC | Apr 18, 2025 | 1 | $1.81K | 4 | May 5, 2025 | Director |
| AGEN | AGENUS INC | Apr 4, 2025 | 1 | $1.81K | 4 | Apr 10, 2025 | Director |
| AGEN | AGENUS INC | Mar 21, 2025 | 1 | $1.81K | 4 | Mar 27, 2025 | Director |
| AGEN | AGENUS INC | Mar 7, 2025 | 1 | $961 | 4 | Mar 24, 2025 | Director |
| AGEN | AGENUS INC | Feb 21, 2025 | 1 | $1.81K | 4 | Mar 11, 2025 | Director |
| AGEN | AGENUS INC | Feb 21, 2025 | 1 | $2.08K | 4 | Mar 5, 2025 | Director |
| AGEN | AGENUS INC | Feb 7, 2025 | 1 | $1.81K | 4 | Feb 18, 2025 | Director |
| AGEN | AGENUS INC | Jan 24, 2025 | 1 | -$964 | 4 | Feb 4, 2025 | Director |
| AGEN | AGENUS INC | Jan 24, 2025 | 1 | $2.77K | 4 | Jan 28, 2025 | Director |
| AGEN | AGENUS INC | Nov 14, 2024 | 1 | $0 | 4 | Nov 18, 2024 | Chairman Executive Council, Director |
| AGEN | AGENUS INC | Jun 11, 2024 | 0 | $0 | 3 | Jun 20, 2024 | Chairman Executive Council, Director |
| PTIX | Protagenic Therapeutics, Inc.\new | Mar 25, 2024 | 1 | $131K | 4 | Mar 29, 2024 | Director |
| INKT | MiNK Therapeutics, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 18, 2024 | Chief Executive Officer |
| INKT | MiNK Therapeutics, Inc. | Oct 11, 2023 | 2 | $0 | 4 | Oct 13, 2023 | Chief Executive Officer, Director |
| INKT | MiNK Therapeutics, Inc. | Sep 29, 2023 | 3 | -$151K | 4 | Oct 3, 2023 | Chief Executive Officer, Director |
| INKT | MiNK Therapeutics, Inc. | Sep 27, 2023 | 2 | $0 | 4 | Sep 29, 2023 | Chief Executive Officer |
| INKT | MiNK Therapeutics, Inc. | Jan 9, 2023 | 2 | $399K | 4 | Jan 11, 2023 | Chief Executive Officer |
| INKT | MiNK Therapeutics, Inc. | Jan 21, 2022 | 1 | $0 | 4 | Jan 25, 2022 | President, Chief Executive Officer, Director |
| INKT | MiNK Therapeutics, Inc. | Oct 13, 2021 | 0 | $0 | 3 | Oct 20, 2021 | President, Chief Executive Officer Exhibit List: Exhibit 24 - Power of Attorney, Director |
| AGEN | AGENUS INC | Jun 15, 2021 | 2 | $58.2K | 4 | Jul 2, 2021 | COO and President |